UEMS Medical Specialty

Metabolic & Endocrinology — Page 2

Nutraceutical approaches to metabolic dysregulation: GLP-1 companion formulas, insulin sensitisers, thyroid support, adipokine modulation, and comprehensive metabolic syndrome management.

28

dossiers

Intracellular Defense & IV-Alternatives

Isomeric Stabilization in High-Moisture Matrices: Protecting Fixed-Ratio Inositol Formulations

Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.

Cerebral Bioenergetics & Neuro-Metabolic Rescue

Ketogenic Diet-Specified Interventions in Neurodegenerative Disease Mechanisms

Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.

Alzheimer DiseaseParkinson DiseaseNeurodegenerative DiseasesNeuroinflammation

Precision Microbiome & Gut-Brain Axis

Enteric Delivery of Butyrate: Overcoming Gastrointestinal Barriers for Vagal Activation

Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.

AgingSerotoninGastrointestinal MicrobiomeFatty Acids, Volatile

Post-GLP-1 Metabolic Optimization

Semaglutide: Gastrointestinal Effects and Post-Discontinuation Weight Regain, 2026

Developing GLP-1 formulations that balance robust metabolic benefits with reduced gastrointestinal side effects and mitigate post-discontinuation weight regain remains a significant challenge. The interplay between appetite modulation, gastrointestinal motility, and adverse event profiles adds complexity to product optimization.

DopamineCardiovascular SystemBrain-Gut AxisGlucagon-Like Peptide 1

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.